ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | +18.2% | 49,119 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | -42.1% | 49,119 | -36.3% | 0.00% | – |
| Q4 2018 | $19,000 | +18.8% | 77,141 | +18.8% | 0.00% | – |
| Q3 2018 | $16,000 | +60.0% | 64,923 | +63.6% | 0.00% | – |
| Q2 2018 | $10,000 | 0.0% | 39,691 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | -9.1% | 39,691 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | +10.0% | 39,691 | -5.3% | 0.00% | – |
| Q3 2017 | $10,000 | -47.4% | 41,925 | -18.2% | 0.00% | – |
| Q2 2017 | $19,000 | +58.3% | 51,280 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | -36.8% | 51,280 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | 0.0% | 51,280 | 0.0% | 0.00% | – |
| Q3 2016 | $19,000 | -87.8% | 51,280 | -66.2% | 0.00% | -100.0% |
| Q1 2014 | $156,000 | -11.4% | 151,905 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $176,000 | -31.8% | 151,905 | -1.2% | 0.00% | 0.0% |
| Q3 2013 | $258,000 | -26.1% | 153,805 | -12.4% | 0.00% | -50.0% |
| Q2 2013 | $349,000 | – | 175,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |